Sigyn Therapeutics Capital Expenditures (CapEx) Growth & History (SIGY)
Sigyn Therapeutics's capital expenditures (capex) was $860 for fiscal 2022.
View full Sigyn Therapeutics company overviewSigyn Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2022 | 2022-12-31 | $860 | −$28,404 | −97.06% |
| 2021 | 2021-12-31 | $29,264 | — | — |
| 2018 | 2018-12-31 | $2,950 | $2,010 | +213.83% |
| 2017 | 2017-12-31 | $940 | — | — |
| 2015 | 2015-12-31 | $2,451 | −$1,014 | −29.26% |
| 2014 | 2014-12-31 | $3,465 | — | — |
Sigyn Therapeutics quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q3 2022 | 2022-09-30 | $1 | −$17,333 | −99.99% |
| Q4 2021 | 2021-12-31 | $9,059 | — | — |
| Q3 2021 | 2021-09-30 | $17,334 | — | — |
| Q2 2021 | 2021-06-30 | $0 | — | — |
| Q1 2021 | 2021-03-31 | $2,871 | — | — |
| Q3 2018 | 2018-09-30 | $77 | $77 | — |
| Q4 2017 | 2017-12-31 | $0 | — | — |
| Q3 2017 | 2017-09-30 | $0 | $0 | — |
| Q2 2017 | 2017-06-30 | $470 | $470 | — |
| Q1 2017 | 2017-03-31 | $470 | −$2,813 | −85.68% |
| Q3 2016 | 2016-09-30 | $0 | — | — |
| Q2 2016 | 2016-06-30 | $0 | — | — |
| Q1 2016 | 2016-03-31 | $3,283 | — | — |
Sigyn Therapeutics capital expenditures (capex) trends
Over the last five fiscal years, Sigyn Therapeutics's capital expenditures (capex) decreased from $940 to $860, a change of −$80. The latest reported quarter, Q3 2022, shows $1.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sigyn Therapeutics source filings ↗